integer Archives - Page 3 of 3 - Medical Design Sourcing

Integer beats The Street in Q3, plans to acquire Oscor

Integer Holdings (NYSE:ITGR) posted third-quarter results today that beat the consensus forecast on Wall Street — and announced plans to spend $220 million to acquire Oscor.

The Plano, Texas–based medtech contract manufacturing giant plans to finance the acquisition with debt. Integer officials expect the deal to close in December under customary closing conditions. They see the acquisition broadening Integer’s product portfolio, expanding its R&D capabilities, and adding low-cost manufacturing capacity.

“We’re excited to welcome Oscor’s approximately 900 associates to Integer, who will bring a trusted brand with 40 years of medical device development and manufacturing combined with a complementary product offering and extensive intellectual property portfolio,” Integer CEO Joseph Dziedzic said in a news release.

Dziedzic suggested that Integer is in a financial position to continue shopping: “The execution of our …

Women in Medtech 2021: Jennifer Bolt, Integer Senior Vice President, Global Operations and ESG

Jennifer Bolt [Photo courtesy of Integer]

Jennifer Bolt is responsible for driving consistent, world class performance across Integer’s global operations. She also oversees the Supply Chain, Lean Enterprise, and Environmental Health, Safety & Security functions.

Under Bolt’s leadership, Integer is implementing sustainable systems that enable the full engagement of the organization to achieve excellence in manufacturing, safety, quality, delivery, responsiveness and efficiency. She also leads efforts to instill a culture of continuous improvement within the company.

During her 15-year career with Integer, Bolt has held numerous executive roles, including leading the Electrochem and Portable Medical businesses, managing supply chain, directing operations across multiple manufacturing facilities and overseeing engineering teams.

Prior to joining Integer in 2005, Bolt spent 12 years at General Mot…

Integer to show off breadth of medical device capabilities at MD&M West

Medical device contract manufacturing giant Integer will show off the breadth of its capabilities at MD&M West week.

Integer will exhibit at booth No. 2951 at the show, which will be held Aug. 10–12 at the Anaheim Convention Center in Anaheim, Calif.

Highlights will include:

Xcellion rechargeable batteries: Integer’s new Xcellion Gen 3 Lithium-ion fast charge rechargeable batteries can reduce charging time by up to 70%, increase battery runtime by up to 30% and retain 70% original capacity after 6,000+ full cycles, according to Integer. Expanded laser cutting capabilities: Integer’s state-of-the-art manufacturing equipment includes fiber laser, femtosecond lasers, swiss lasers and more. The company’s engineers can apply their expertise to a broad range of product applications, including NiTi frames for EP catheters and stone retrieval devices, support structures for clot retrieval devices, endoscope components, stents, heart valve scaffolds, laser cut …

Integer beats The Street in Q2, boosts sales outlook

Integer Holdings (NYSE:ITGR) posted second-quarter results today that beat the consensus forecast on Wall Street — boosting its 2021 sales outlook amid continued recovery from the COVID-19 pandemic.

The Plano, Texas–based medical device contract manufacturing giant reported profits of $29.4 million, or 89¢ per share, on sales of $312.0 million for the three months ended July 2, 2021. The results mark a major improvement over Q2 2020, when Integer earned $389,000 on sales of 240.1 million.

Adjusted to exclude one-time items, earnings per share were $1.07, 16¢ ahead of The Street, where analysts were looking for EPS of 91¢ on sales of $294.17 million.

Get the full story on our sister site Medical Design & Outsourcing.

Integer beats The Street in Q2, boosts sales outlook

Integer Holdings (NYSE:ITGR) posted second-quarter results today that beat the consensus forecast on Wall Street — boosting its 2021 sales outlook amid continued recovery from the COVID-19 pandemic.

The Plano, Texas–based medical device contract manufacturing giant reported profits of $29.4 million, or 89¢ per share, on sales of $312.0 million for the three months ended July 2, 2021. The results mark a major improvement over Q2 2020, when Integer earned $389,000 on sales of 240.1 million.

Adjusted to exclude one-time items, earnings per share were $1.07, 16¢ ahead of The Street, where analysts were looking for EPS of 91¢ on sales of $294.17 million.

“Integer delivered strong growth versus last year on continued recovery from the pandemic,” Integer CEO Joseph Dziedzic said in a news release. “These results demonstrate the resiliency of Integer’s associates to deliver for customers and patients despite the U.S. labor constraints and global supply chain dis…

Integer wins appeal in patent dispute with AVX

An appeals court has upheld a $22.2 million jury verdict in a long-standing patent spat between Integer Holdings (NYSE:ITGR), formerly known as Greatbatch, and AVX, now part of Kyocera.

In a ruling released today, a three-judge panel of the U.S. Court of Appeals agreed with a lower court decision that AVX intentionally infringed certain Integer patents with its Ingenio filtered feedthrough assembly (FFT) devices. Integer originally filed a patent infringement complaint in April 2013, alleging that AVX infringed on patents related to the FFTs used in its implantable pacers and cardioverter defibrillators.

Get the full story on our sister site, Medical Design & Outsourcing.